Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more

White Paper: Health Economic Evidence Requirements for Medical Devices in Europe

Get insights from MTRC White Papers to discover health economic evidence requirements and best practices for market access in the EU5

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Health Economic Publication Digest: Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest.

In a recent publication, Maervoet et al. compared the newly recommended NICE Decision Support Unit (DSU) mapping function for EQ-5D-5L to EQ-5D-3L with the previously endorsed van Hout Crosswalk. An analysis of all 3,125 health states and synthetic patient simulations showed that the DSU approach produced higher utility values in 61% of cases, with an average difference of +0.062. The findings highlighted that mapping choice can shift utility estimates and may affect NICE decision-making.

Access the full-text article here.